Capital International Sarl Purchases 78,792 Shares of The Cooper Companies, Inc. $COO

Capital International Sarl raised its holdings in The Cooper Companies, Inc. (NASDAQ:COO) by 72.2% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 187,857 shares of the medical device company’s stock after buying an additional 78,792 shares during the period. Capital International Sarl’s holdings in Cooper Companies were worth $12,879,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also recently modified their holdings of COO. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in Cooper Companies by 48.9% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 22,407 shares of the medical device company’s stock worth $1,890,000 after buying an additional 7,363 shares in the last quarter. Assetmark Inc. raised its holdings in shares of Cooper Companies by 357.8% in the second quarter. Assetmark Inc. now owns 618 shares of the medical device company’s stock valued at $44,000 after purchasing an additional 483 shares during the last quarter. Resona Asset Management Co. Ltd. lifted its position in shares of Cooper Companies by 7.9% during the second quarter. Resona Asset Management Co. Ltd. now owns 67,988 shares of the medical device company’s stock valued at $4,838,000 after purchasing an additional 4,976 shares in the last quarter. Wedbush Securities Inc. boosted its holdings in Cooper Companies by 13.5% during the second quarter. Wedbush Securities Inc. now owns 13,860 shares of the medical device company’s stock worth $986,000 after purchasing an additional 1,648 shares during the last quarter. Finally, Fox Run Management L.L.C. bought a new stake in Cooper Companies in the 2nd quarter worth about $514,000. 24.39% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on the company. Barclays upped their target price on Cooper Companies from $98.00 to $103.00 and gave the company an “overweight” rating in a report on Friday. Rothschild & Co Redburn lowered Cooper Companies from a “buy” rating to a “neutral” rating and set a $85.00 target price on the stock. in a research note on Wednesday, March 4th. Stifel Nicolaus set a $95.00 price objective on shares of Cooper Companies and gave the company a “buy” rating in a report on Friday, December 5th. KeyCorp reiterated a “sector weight” rating on shares of Cooper Companies in a research note on Friday, December 5th. Finally, Morgan Stanley upped their price target on shares of Cooper Companies from $76.00 to $83.00 and gave the company an “equal weight” rating in a research note on Monday, December 8th. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, Cooper Companies currently has a consensus rating of “Moderate Buy” and a consensus target price of $90.79.

Key Cooper Companies News

Here are the key news stories impacting Cooper Companies this week:

• Positive Sentiment: Insiders (CEO, directors and other executives) purchased shares in recent months, reinforcing management confidence in the business and complementing continuing share repurchases — a constructive signal for investors. CooperCompanies Insiders Buy as Rebound Setup Forms
• Positive Sentiment: An unnamed report raised Cooper’s price target to $103, reflecting upside from current levels and highlighting bullish analyst conviction after the quarter and buyback activity. Cooper Companies (NASDAQ:COO) Price Target Raised to $103.00
• Neutral Sentiment: Analyst/education pieces (Zacks) reiterate Cooper as a longer-term value/quality healthcare name but flag the importance of monitoring international revenue trends — useful for longer-horizon investors but not immediate catalysts. Why The Cooper Companies (COO) is a Top Value Stock for the Long-Term
• Neutral Sentiment: Another Zacks piece recommends watching geographic/international revenue trends for their impact on estimates — informative but not an immediate driver. Investing in The Cooper Companies (COO)? Don’t Miss Assessing Its International Revenue Trends
• Negative Sentiment: Citigroup reduced its price target to $87, signaling caution from some institutional analysts despite the recent earnings beat; conflicting analyst views are likely contributing to short-term selling pressure. Citigroup Cuts Cooper Companies (NASDAQ:COO) Price Target to $87.00

Insider Buying and Selling at Cooper Companies

In other news, Director Cynthia L. Lucchese acquired 1,784 shares of the business’s stock in a transaction dated Monday, December 22nd. The stock was purchased at an average cost of $84.06 per share, for a total transaction of $149,963.04. Following the acquisition, the director owned 9,445 shares of the company’s stock, valued at $793,946.70. This trade represents a 23.29% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Albert G. White III bought 10,000 shares of the business’s stock in a transaction on Tuesday, December 16th. The stock was purchased at an average cost of $80.80 per share, with a total value of $808,000.00. Following the purchase, the chief executive officer owned 236,151 shares of the company’s stock, valued at $19,081,000.80. This represents a 4.42% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders bought 16,014 shares of company stock valued at $1,304,416 over the last 90 days. Insiders own 2.08% of the company’s stock.

Cooper Companies Trading Down 1.0%

Shares of Cooper Companies stock opened at $75.82 on Tuesday. The company’s 50-day moving average price is $81.98 and its 200-day moving average price is $76.02. The company has a current ratio of 1.34, a quick ratio of 0.79 and a debt-to-equity ratio of 0.22. The Cooper Companies, Inc. has a 12-month low of $61.78 and a 12-month high of $89.83. The company has a market cap of $14.79 billion, a price-to-earnings ratio of 37.53, a PEG ratio of 2.13 and a beta of 1.02.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings data on Thursday, March 5th. The medical device company reported $1.10 EPS for the quarter, beating the consensus estimate of $1.03 by $0.07. The company had revenue of $1.02 billion during the quarter, compared to analysts’ expectations of $1.02 billion. Cooper Companies had a net margin of 9.67% and a return on equity of 10.34%. Cooper Companies’s revenue for the quarter was up 6.2% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.92 earnings per share. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS. On average, equities analysts expect that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.